Envoy Medical, Inc. COCH
6.62 USD -0.03 (-0.45%)
At closeNov 3, 2026, 4:00 PM EST
6.62 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
6.59 Day range 7.00
3.63 52-week range 9.54
- YTD
- +0.15%
- 1 year
- -13.35%
Financial health
Altman Z-Score
-20.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2020 5y median -1.0× FY 2025
P/S 63.8×
FY 2020 5y median 119× FY 2025
P/B -1.3×
FY 2020 5y median -2.2× FY 2025
P/FCF -0.8×
FY 2020 5y median -1.4× FY 2025
EV/EBITDA -0.6×
FY 2020 5y median -2.1× FY 2025
EV/Sales 52.1×
FY 2020 5y median 182× FY 2025
FCF Yield -119.5%
FY 2020 5y median -70.4% FY 2025
Profitability
Gross Margin -262.7%
FY 2020 5y median -149.7% FY 2025
Operating Margin -9240.7%
FY 2020 5y median -5809.8% FY 2025
Net Margin -9857.3%
FY 2020 5y median -9242.2% FY 2025
ROE 201.9%
FY 2020 5y median 110.4% FY 2025
ROIC 786.9%
FY 2020 5y median -554.1% FY 2025
ROA -277.6%
FY 2020 5y median -330.6% FY 2025
Growth (YoY)
Revenue 7.1%
FY 2020 FY 2025
Operating Income -15.7%
FY 2020 FY 2025
EPS (diluted) 17.4%
FY 2020 FY 2025
Free Cash Flow 2.9%
FY 2020 FY 2025
Financial Health
Current Ratio 0.5×
FY 2020 5y median 1.0× FY 2025
Quick Ratio 0.4×
FY 2020 5y median 0.8× FY 2025
Debt / Equity -0.1×
FY 2020 5y median -0.5× FY 2025
Net Debt / EBITDA 0.1×
FY 2020 5y median -0.7× FY 2025
Interest Coverage -14.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 11.8%
FY 2020 5y median 0.0% FY 2025
Payout Ratio -7.7%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
